A pilot randomized controlled trial of a tailored smoking cessation program for people living with HIV in the Washington, D.C. metropolitan area
| dc.contributor.author | Kierstead, Elexis C. | en |
| dc.contributor.author | Harvey, Emily | en |
| dc.contributor.author | Sanchez, Denisse | en |
| dc.contributor.author | Horn, Kimberly A. | en |
| dc.contributor.author | Abroms, Lorien C. | en |
| dc.contributor.author | Spielberg, Freya | en |
| dc.contributor.author | Stanton, Cassandra A. | en |
| dc.contributor.author | Debnam, Charles | en |
| dc.contributor.author | Cohn, Amy M. | en |
| dc.contributor.author | Gray, Tiffany | en |
| dc.contributor.author | Magnus, Manya | en |
| dc.contributor.author | Patel, Minal | en |
| dc.contributor.author | Niaura, Raymond | en |
| dc.contributor.author | Elf, Jessica L. | en |
| dc.date.accessioned | 2021-01-11T12:40:55Z | en |
| dc.date.available | 2021-01-11T12:40:55Z | en |
| dc.date.issued | 2021-01-06 | en |
| dc.date.updated | 2021-01-10T04:14:06Z | en |
| dc.description.abstract | Abstract Objective Morbidity and mortality from smoking-related diseases among people living with HIV (PLWH) in the U.S. surpasses that due to HIV itself. Conventional smoking cessation treatments have not demonstrated strong efficacy among PLWH. We conducted a pilot randomized controlled trial (RCT) to evaluate a tailored smoking cessation intervention based on the minority stress model. We compared standard of care counseling (SOC) to a tailored intervention (TI) including one face-to-face counseling session incorporating cognitive behavioral therapy to build resilience, and 30 days of 2-way text messaging. Results The primary outcome was smoking cessation. Secondary outcomes included cigarettes per day (CPD), exhaled carbon monoxide (CO), and cessation self-efficacy. A total of 25 participants were enrolled (TI:11, SOC:14), and 2 were lost to follow-up. There were no significant differences in quit rates between study groups. However, there was a significantly greater decrease in CPD in the TI versus SOC (13.5 vs. 0.0, p-value:0.036). Additionally, self-efficacy increased in both groups (TI p-value:0.012, SOC p-value:0.049) and CO decreased in both groups (TI p-value: < 0.001, SOC p-value:0.049). This intervention shows promise to support smoking cessation among PLWH. A larger study is needed to fully evaluate the efficacy of this approach. Clinical trial: Trial Registration: Retrospectively registered (10/20/2020) NCT04594109. | en |
| dc.description.version | Published version | en |
| dc.format.mimetype | application/pdf | en |
| dc.identifier.citation | BMC Research Notes. 2021 Jan 06;14(1):2 | en |
| dc.identifier.doi | https://doi.org/10.1186/s13104-020-05417-3 | en |
| dc.identifier.uri | http://hdl.handle.net/10919/101824 | en |
| dc.language.iso | en | en |
| dc.rights | Creative Commons Attribution 4.0 International | en |
| dc.rights.holder | The Author(s) | en |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
| dc.title | A pilot randomized controlled trial of a tailored smoking cessation program for people living with HIV in the Washington, D.C. metropolitan area | en |
| dc.title.serial | BMC Research Notes | en |
| dc.type | Article - Refereed | en |
| dc.type.dcmitype | Text | en |
| dc.type.dcmitype | StillImage | en |